The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes

A Large Candidate Gene Survey Identifies the KCNE1 D85N Polymorphism as a Possible Modulator of Drug-Induced Torsades de Pointes

(2011) Stefan Kääb et al.   Circulation-Cardiovascular Genetics

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

(2011) M Pirmohamed et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

(2011) G P Aithal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Phenotype Standardization Project: Improving Pharmacogenetic Studies of Serious Adverse Drug Reactions

(2011) M Pirmohamed et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously

(2011) A. Ronaszeki et al.   EUROPACE

The site of origin of torsade de pointes

(2011) E. Y. Birati et al.   HEART

Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome

(2009) Hideki Itoh et al.   Circulation-Arrhythmia and Electrophysiology

Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome

(2009) Paulus Kirchhof et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Near-Thorough QT Study as Part of a First-In-Man Study

(2008) Marek Malik et al.   JOURNAL OF CLINICAL PHARMACOLOGY